ROI Highlights
Real results for organizations managing chronic disease at scale
As the costs of chronic conditions continue to rise, employers and health plans seek solutions that improve health outcomes and deliver measurable financial value. Vida’s clinically driven programs for obesity and diabetes go beyond coaching—they deliver whole-person care through evidence-based interventions, licensed providers, and integrated behavioral health support.
The results speak for themselves
Vida’s programs reduce medical and pharmacy costs within the first year. Here’s what organizations can expect when obesity and diabetes are treated together through clinical, coordinated care. On average, our cardiometabolic programs deliver:
$2,048
annual medical cost savings per engaged member (reduction in ER visits and hospitalizations)
$550
PMPM savings in avoided GLP-1 prescriptions
94%
medication adherence for members on GLP-1s (in contrast to 47% GLP-1 persistence rate outside Vida)*
Vida’s approach helps avoid unnecessary medication costs, ensures high adherence members appropriately prescribed weight loss medications, and reduces costly medical events—all contributing to a stronger, more efficient ROI.
*Gleason et al. J Manag Care Spec Pharm. 2024;30(8).
Clinical Obesity Management Program
Driving down costs through sustained weight loss
Vida’s Clinical Obesity Management Program combines medical oversight, Medical Nutrition Therapy, and lifestyle change support to drive meaningful, sustainable weight loss.

Clinical Obesity Management Plus
Coordinated care for obesity, diabetes, and related conditions
Vida’s Clinical Obesity Management Plus program takes a comprehensive approach to chronic disease by treating obesity and diabetes together—along with other related conditions like hypertension and high cholesterol. This integrated model doesn’t just improve health; it helps employers manage the rising costs of medications, including GLP-1s and insulin.


Lower Costs, Better Control
By focusing on whole-person care—including medical oversight, behavior change, nutrition therapy, and mental health support—we help members improve metabolic health and reduce reliance on expensive prescriptions. This leads to:
- 2.4-point reduction in A1C at 12 months
- 15% fewer ER visits and hospitalizations
- More stable, predictable outcomes at the population level
Bring these results to your workforce
Together, Vida’s obesity and diabetes programs offer a high-impact strategy for controlling costs and pharmacy spending. Our integrated approach not only boosts the effectiveness of GLP-1s—it helps avoid unnecessary prescriptions and downstream complications, leading to lower total cost of care, stronger medication ROI, and a more sustainable path to chronic condition management.